320 related articles for article (PubMed ID: 11500805)
41. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
[TBL] [Abstract][Full Text] [Related]
42. Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival.
Kadekaro AL; Kanto H; Kavanagh R; Abdel-Malek Z
Ann N Y Acad Sci; 2003 Jun; 994():359-65. PubMed ID: 12851336
[TBL] [Abstract][Full Text] [Related]
43. Multiplex melanoma families are enriched for polygenic risk.
Law MH; Aoude LG; Duffy DL; Long GV; Johansson PA; Pritchard AL; Khosrotehrani K; Mann GJ; Montgomery GW; Iles MM; Cust AE; Palmer JM; ; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Saw RPM; Scolyer RA; Martin NG; Hayward NK; MacGregor S
Hum Mol Genet; 2020 Oct; 29(17):2976-2985. PubMed ID: 32716505
[TBL] [Abstract][Full Text] [Related]
44. The melanocortin-1-receptor gene is the major freckle gene.
Bastiaens M; ter Huurne J; Gruis N; Bergman W; Westendorp R; Vermeer BJ; Bouwes Bavinck JN
Hum Mol Genet; 2001 Aug; 10(16):1701-8. PubMed ID: 11487574
[TBL] [Abstract][Full Text] [Related]
45. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
46. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation.
Flanagan N; Healy E; Ray A; Philips S; Todd C; Jackson IJ; Birch-Machin MA; Rees JL
Hum Mol Genet; 2000 Oct; 9(17):2531-7. PubMed ID: 11030758
[TBL] [Abstract][Full Text] [Related]
47. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
[TBL] [Abstract][Full Text] [Related]
48. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
Ciotti P; Struewing JP; Mantelli M; Chompret A; Avril MF; Santi PL; Tucker MA; Bianchi-Scarrà G; Bressac-de Paillerets B; Goldstein AM
Am J Hum Genet; 2000 Aug; 67(2):311-9. PubMed ID: 10869234
[TBL] [Abstract][Full Text] [Related]
49. Management of familial melanoma.
Bishop JN; Harland M; Randerson-Moor J; Bishop DT
Lancet Oncol; 2007 Jan; 8(1):46-54. PubMed ID: 17196510
[TBL] [Abstract][Full Text] [Related]
50. Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells.
Newton RA; Smit SE; Barnes CC; Pedley J; Parsons PG; Sturm RA
Peptides; 2005 Oct; 26(10):1818-24. PubMed ID: 15992961
[TBL] [Abstract][Full Text] [Related]
51. The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes.
Sturm RA; Duffy DL; Box NF; Chen W; Smit DJ; Brown DL; Stow JL; Leonard JH; Martin NG
Pigment Cell Res; 2003 Jun; 16(3):266-72. PubMed ID: 12753400
[TBL] [Abstract][Full Text] [Related]
52. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
[TBL] [Abstract][Full Text] [Related]
53. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
[TBL] [Abstract][Full Text] [Related]
55. A common variant of CDKN2A (p16) predisposes to breast cancer.
Debniak T; Górski B; Huzarski T; Byrski T; Cybulski C; Mackiewicz A; Gozdecka-Grodecka S; Gronwald J; Kowalska E; Haus O; Grzybowska E; Stawicka M; Swiec M; Urbański K; Niepsuj S; Waśko B; Góźdź S; Wandzel P; Szczylik C; Surdyka D; Rozmiarek A; Zambrano O; Posmyk M; Narod SA; Lubinski J
J Med Genet; 2005 Oct; 42(10):763-5. PubMed ID: 15879498
[TBL] [Abstract][Full Text] [Related]
56. High polymorphism at the human melanocortin 1 receptor locus.
Rana BK; Hewett-Emmett D; Jin L; Chang BH; Sambuughin N; Lin M; Watkins S; Bamshad M; Jorde LB; Ramsay M; Jenkins T; Li WH
Genetics; 1999 Apr; 151(4):1547-57. PubMed ID: 10101176
[TBL] [Abstract][Full Text] [Related]
57. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma.
Valverde P; Healy E; Sikkink S; Haldane F; Thody AJ; Carothers A; Jackson IJ; Rees JL
Hum Mol Genet; 1996 Oct; 5(10):1663-6. PubMed ID: 8894704
[TBL] [Abstract][Full Text] [Related]
58. In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants.
Hernando B; Swope VB; Guard S; Starner RJ; Choi K; Anwar A; Cassidy P; Leachman S; Kadekaro AL; Bennett DC; Abdel-Malek ZA
Pigment Cell Melanoma Res; 2019 Mar; 32(2):259-268. PubMed ID: 30117292
[TBL] [Abstract][Full Text] [Related]
59. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients.
Metzelaar-Blok JA; ter Huurne JA; Hurks HM; Keunen JE; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1951-4. PubMed ID: 11481256
[TBL] [Abstract][Full Text] [Related]
60. CDKN2A variants in a population-based sample of Queensland families with melanoma.
Aitken J; Welch J; Duffy D; Milligan A; Green A; Martin N; Hayward N
J Natl Cancer Inst; 1999 Mar; 91(5):446-52. PubMed ID: 10070944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
